Medrobotics Corporation, a Raynham, Massachusetts-based surgical products company focused on medical robotics, closed a $25m financing.
Existing shareholders participated in the financing.
The company intends to use the funds to expand the commercial efforts for the Flex® Robotic System.
Led by President & CEO Samuel F. Straface, Ph.D., Medrobotics manufactues and markets the Flex® Robotic System, a minimally-invasive surgical, robot-assisted platform that allows surgeons to access, visualize, and deliver surgical instruments to anatomical locations which are usually hard to reach with traditional surgical methods.
The company received FDA clearance for the Flex® Robotic System in 2015, and the CE mark in 2014.